Director, Individualized Therapy Operations, US Oncology Marketing

The U.S. Oncology business within our company is a growing and dynamic organization committed to advancing innovative therapies for patients with cancer. We have an exciting opportunity to join our dynamic commercial team as we prepare for the potential U.S. launch of an mRNA-based individualized neoantigen therapy for early-stage melanoma, being developed through an alliance partnership. This novel product has the potential to redefine personalized cancer treatment and requires a highly coordinated operating model to support seamless therapy delivery across a complex treatment ecosystem. Reporting to the Executive Director, U.S. Oncology Marketing, Moderna Alliance, the Director, Individualized Therapy Operations serves as the U.S. commercial leader accountable for the strategy, design, and execution of the product end-to-end operational ecosystem, ensuring a seamless, and scalable process to support this individualized therapy product. This leader will oversee the operational strategy, capabilities, processes, and governance across the Intismeran operational ecosystem to ensure seamless coordination and integration across sample and tissue operations, logistics coordination, manufacturing demand planning, operational performance management, and customer support. The role will coordinate across our company, alliance partner, sequencing providers, distributors, and treatment sites to ensure reliable therapy delivery and treatment completion. As the commercial owner of the end-to-end operational ecosystem, this individual will lead the development of the capabilities, governance, and operational infrastructure required to support launch readiness, commercial scale, and future growth. The role will also oversee the organization responsible for centralized coordination, partner management, capacity planning, analytics, and operational excellence.

Serve as the US commercial owner of the Intismeran end-to-end operational ecosystem, accountable for designing, integrating, and optimizing the capabilities, processes, and stakeholder interactions required to support a seamless, scalable, and compliant treatment journey from order through treatment administration. Define and lead the end-to-end operational strategy and governance framework required to support launch readiness, commercial execution, future growth, and long-term scalability, including governance, operating cadence, escalation pathways, and performance standards. Own the Intismeran orchestration ecosystem, including operational workflows, digital orchestration capabilities, sample and tissue operations, logistics coordination, customer support capabilities, and treatment journey process integration. Lead cross-functional alignment across internal and external stakeholders, including Manufacturing, Supply Chain, Precision Medicine, IT, Market Access, Patient Support Programs, Treatment Site Strategy, alliance stakeholders, sequencing providers, distributors, and treatment sites to ensure reliable therapy delivery and treatment completion. Provide strategic leadership and oversight of the Treatment Site Operations Coordinator (TSOC) capability, ensuring the centralized coordination model, workflows, governance, and performance standards effectively support seamless treatment journey execution across treatment sites, manufacturing, logistics, and internal partners. Establish and oversee operational performance management, including enterprise KPIs, service level objectives, dashboards, operational demand planning, capacity planning, risk management, and executive reporting to drive data-based decision making and operational excellence. Lead operational governance and control tower activities, proactively identifying and resolving operational barriers, exceptions, and capacity constraints while driving initiatives that improve efficiency, customer experience, and treatment completion. Build and evolve future-state capabilities required